|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 51.18 USD | +1.04% |
|
+0.28% | -9.64% |
| Capitalization | 103B 88.53B 82.8B 77.35B 143B 9,268B 155B 960B 374B 4,393B 387B 379B 16,123B | P/E ratio 2025 * |
11.9x | P/E ratio 2026 * | 10.9x |
|---|---|---|---|---|---|
| Enterprise value | 136B 117B 110B 102B 189B 12,257B 205B 1,270B 495B 5,810B 512B 501B 21,323B | EV / Sales 2025 * |
2.84x | EV / Sales 2026 * | 2.95x |
| Free-Float |
67.93% | Yield 2025 * |
4.88% | Yield 2026 * | 5.03% |
Last Transcript: Bristol-Myers Squibb Company
| 1 day | +0.91% | ||
| 1 week | +0.28% | ||
| Current month | +3.87% | ||
| 1 month | +8.14% | ||
| 3 months | +8.39% | ||
| 6 months | +2.27% | ||
| Current year | -9.64% |
| 1 week | 50.22 |  | 52.51 |
| 1 month | 45.26 | | 52.51 |
| Current year | 42.52 | | 63.33 |
| 1 year | 42.52 | | 63.33 |
| 3 years | 39.35 | | 79.36 |
| 5 years | 39.35 | | 81.44 |
| 10 years | 39.35 | | 81.44 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 54 | 31/10/2023 | |
David Elkins
DFI | Director of Finance/CFO | 57 | 19/11/2019 |
| Compliance Officer | - | 30/09/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 54 | 31/03/2024 | |
Peter Arduini
BRD | Director/Board Member | 60 | 31/03/2016 |
Theodore Samuels
BRD | Director/Board Member | 70 | 20/02/2017 |
| Name | Weight | AuM | Varia. Jan 1. | Investor |
|---|---|---|---|---|
 | 12.97% | 303 M€ | -22.62% | - |
| 4.01% | 26 M€ | +11.19% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.04% | +0.28% | -12.07% | -35.22% | 103B | |
| +1.38% | -3.87% | +24.27% | +170.55% | 879B | |
| +2.26% | -0.33% | +37.13% | +15.07% | 482B | |
| +0.20% | -2.89% | +27.27% | +35.24% | 394B | |
| +2.12% | +2.61% | +26.87% | +6.27% | 335B | |
| -0.57% | -1.31% | +28.56% | +19.07% | 281B | |
| -1.31% | -1.84% | +18.77% | +24.13% | 254B | |
| +0.37% | -4.85% | -3.65% | -10.70% | 240B | |
| +3.31% | +1.74% | -60.50% | -32.27% | 207B | |
| +0.65% | -8.51% | +14.61% | +14.18% | 169B | |
| Average | +0.91% | -1.86% | +10.13% | +20.63% | 334.47B | |
| Weighted average by Cap. | +1.06% | -2.75% | +17.81% | +52.09% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 48B 41.21B 38.54B 36.01B 66.43B 4,314B 72.28B 447B 174B 2,045B 180B 176B 7,505B | 44.05B 37.82B 35.37B 33.04B 60.97B 3,959B 66.34B 410B 160B 1,877B 165B 162B 6,888B |
| Net income | 8.26B 7.09B 6.63B 6.2B 11.44B 743B 12.44B 76.93B 29.98B 352B 31.01B 30.35B 1,292B | 9.26B 7.95B 7.43B 6.94B 12.81B 832B 13.94B 86.19B 33.59B 394B 34.74B 34B 1,448B |
| Net Debt | 33.26B 28.55B 26.7B 24.95B 46.03B 2,989B 50.09B 310B 121B 1,417B 125B 122B 5,200B | 26.84B 23.05B 21.55B 20.13B 37.15B 2,413B 40.42B 250B 97.38B 1,144B 101B 98.59B 4,197B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/12/25 | 51.10 $ | +0.90% | 3,927,319 |
| 09/12/25 | 50.65 $ | -1.97% | 12,715,403 |
| 08/12/25 | 51.67 $ | -0.92% | 15,278,685 |
| 05/12/25 | 52.15 $ | +0.38% | 15,667,697 |
| 04/12/25 | 51.95 $ | +1.94% | 20,473,113 |
Delayed Quote Nyse, December 10, 2025 at 06:27 pm
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- BMY Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition